R57K polymorphism in the human immunodeficiency virus type 1 protease as predictor of early virological failure in a cohort of antiretroviral-naive patients treated mostly with a nelfinavir-containing regimen.
about
Ninety-Nine Is Not Enough: Molecular Characterization of Inhibitor-Resistant Human Immunodeficiency Virus Type 1 Protease Mutants with Insertions in the Flap RegionViral Genetic Diversity and Polymorphisms in a Cohort of HIV-1-Infected Patients Eligible for Initiation of Antiretroviral Therapy in Abuja, Nigeria.Emergence of drug resistance-associated mutations in HIV-1 subtype C protease gene in north India.
P2860
R57K polymorphism in the human immunodeficiency virus type 1 protease as predictor of early virological failure in a cohort of antiretroviral-naive patients treated mostly with a nelfinavir-containing regimen.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
R57K polymorphism in the human ...... nelfinavir-containing regimen.
@en
type
label
R57K polymorphism in the human ...... nelfinavir-containing regimen.
@en
prefLabel
R57K polymorphism in the human ...... nelfinavir-containing regimen.
@en
P2093
P2860
P50
P1476
R57K polymorphism in the human ...... nelfinavir-containing regimen.
@en
P2093
APROCO/COPILOTE Study Group
Bernard Masquelier
Cecile Droz
Christian Perronne
François Raffi
Martin Dary
Virginie Ferré
P2860
P304
P356
10.1128/AAC.47.11.3623-3626.2003
P407
P577
2003-11-01T00:00:00Z